<DOC>
	<DOCNO>NCT00637923</DOCNO>
	<brief_summary>The purpose study determine nitazoxanide combination peginterferon alfa-2a ribavirin safe effective treat chronic hepatitis C treatment-naive patient .</brief_summary>
	<brief_title>Study Nitazoxanide , Peginterferon Alfa-2a Ribavirin Treatment-Naive Hepatitis C Patients</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<mesh_term>Nitazoxanide</mesh_term>
	<criteria>Chronic hepatitis C genotype 1 . Patients previously receive treatment interferon interferonbased treatment chronic hepatitis C. Females childbearing age either pregnant , breastfeed use birth control sexually active . Males whose female partner either pregnant childbearing potential use birth control sexually active . Other cause liver disease include autoimmune hepatitis . Transplant recipient receive immune suppression therapy . Screening test positive AntiHepatitis A Virus Immunoglobulin M Antibody ( antiHAV IgM Ab ) , Hepatitis B 's antigen ( HBsAg ) , AntiHepatitis B core Immunoglobulin M Antibody ( antiHBc IgM Ab ) AntiHuman Immunodeficiency Virus Antibody ( antiHIV Ab ) . Decompensated cirrhosis , history variceal bleeding , ascites , hepatic encephalopathy , ChildTurcottePugh ( CTP ) score &gt; 6 Model Endstage Liver Disease ( MELD ) score &gt; 8 . Alcohol consumption &gt; 40 gram per day alcohol use pattern interfere study . Absolute neutrophil count &lt; 1500 cells/mm3 ; platelet count &lt; 135,000 cells/mm3 ; hemoglobin &lt; 12 g/dL woman &lt; 13 g/dL men ; serum creatinine concentration â‰¥1.5 time Upper Limit Normal ( ULN ) . Hypothyroidism hyperthyroidism effectively treat medication . Hemoglobin A1C ( HgbA1c ) &gt; 7.5 history diabetes mellitus . Body Mass Index ( BMI ) &gt; 34 . History clinical evidence significant unstable cardiac disease . History clinical evidence chronic pulmonary disease associate functional impairment . Serious severe bacterial infection ( ) . Ulcerative hemorrhagic/ischemic colitis . Pancreatitis . History severe uncontrolled psychiatric disease , include severe depression , history suicidal ideation , suicidal attempt psychosis require medication and/or hospitalization . History uncontrolled severe seizure disorder . Requires concomitant theophylline methadone . History immunologically mediate disease require intermittent antiinflammatory medication management require frequent prolong use corticosteroid . History evidence severe retinopathy clinically relevant ophthalmological disorder due diabetes mellitus hypertension . Hemoglobinopathies . History hypersensitivity intolerance nitazoxanide excipients comprise nitazoxanide tablet , peginterferon alfa2a injectable solution ribavirin tablet .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Hepatitis C , Chronic</keyword>
</DOC>